Noah Berkowitz, M.D., Ph.D.
Dr. Berkowitz earned his B.A., M.D.,
and Ph.D. from Columbia University and trained at the National Cancer
Institute in medical oncology. Prior to founding HaptoGuard, he was a
consultant to a variety of biotechnology companies in Israel including
Predix Pharmaceuticals, IDGene and Teva. He was previously Vice
President of Clinical Development at IMPATH Inc.
Dr. Noah Berkowitz - Facebook
